Genomics & Biotech Innovation ETFs
ARKG — ARK Genomic Revolution ETF
ARK · Active · since 2014
Actively managed, concentrated bets on gene editing, molecular diagnostics and agricultural biology.
- Expense ratio
- 0.75%
- AUM
- $1.3B
- Dividend yield
- 0.0%
- 1Y return
- +18.4%
- 3Y ann.
- -3.6%
- 5Y ann.
- -14.1%
- 10Y ann.
- —
- All-time ann.
- —
Top holdings
- Twist Bioscience8.40%
- Recursion Pharmaceuticals7.10%
- Tempus AI6.40%
- CRISPR Therapeutics5.90%
- Guardant Health5.10%
40 total holdings · 51.0% in the top 10